Biotechnology News

September 15, 2014

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley announces Medtronic CEO Omar Ishrak to speak at conference on November 19. Other keynotes come from Mayo Clinic, SharedClarity and BlueCross BlueShield Assoc.

September 15, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that it has...

September 15, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary...

September 15, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that Kevin D. Cordell has been appointed President, U.S. Extremities, effective September 29, 2014. Mr. Cordell will have operating responsibility for...

September 15, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) and Mevion Medical Systems, Inc., two companies that are leading the field of proton therapy, are announcing a partnership to develop advanced treatment planning...

September 15, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Odanacatib is Merck’s investigational once-weekly cathepsin K inhibitor

September 15, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Novalis Circle community examines the emerging role of radiosurgery for aggressive, personalized cancer treatment.

September 15, 2014

PARK CITY, Utah--(BUSINESS WIRE)--Andre Bouhasin, MD, an Interventional Cardiologist with West County Heart and Vascular Diagnostics, St. Louis, Missouri, used a novel device to remove blood clots and emboli from a protective filter and native...

September 15, 2014

BROOKLYN, N.Y.--(BUSINESS WIRE)--Endocrine Technology, L.L.C. is a New York-based biotechnology company detailed at www.etbondusa.com. Kumar Shah, M.D., President of the company,...

September 15, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services,...

September 15, 2014

--(BUSINESS WIRE)--BIO and cellulosic biofuel companies Abengoa, POET-DSM, and GranBio will update the status of cellulosic biofuel production during this teleconference for reporters.

September 15, 2014

COLUMBUS, Ohio--(BUSINESS WIRE)--Last autumn, Ohio’s bioscience industry convened its Annual Conference in its most central metropolis, Columbus. This year, however, BioOhio changes the scope of its Annual Conference by taking it “on the road.”...

September 15, 2014

PLYMOUTH, Minn.--(BUSINESS WIRE)--Rotation Medical Initiates Post-Market Clinical Study of Rotator Cuff Repair System with Bioinductive Implant

September 15, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) today announced the European launch of the 4Kscore ™ Test, the only blood test that accurately identifies risk for aggressive prostate cancer, through its wholly owned subsidiary, OPKO Health...

September 15, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies, announced today that it has expanded its series C financing with an...

September 15, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--The United States FDA has approved Baxter's RIXUBIS for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management in children with hemophilia B.

September 15, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, a clinical-stage biotechnology company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the appointment of Lawrence M. Alleva, a former partner with...

September 15, 2014

ALAMEDA, Calif. & LONDON--(BUSINESS WIRE)--OncoCyte Corporation, a subsidiary of BioTime, Inc. (NYSE MKT: BTX), and Abcodia Ltd., a UK-based company focusing on the early detection of cancer, today announced their collaboration focused on the...

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi acquired rights to GsMTx-4, a small molecule developed by Tonus Therapeutics to address calcium level imbalance in muscle, a critical issue in DMD contributing to loss of function.

September 15, 2014

--(BUSINESS WIRE)--Tech Council of Maryland Debuts Technology Community Speaker Series on October 7 with CEA’s Gary Shapiro

September 15, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the appointment of Sandra E. Poole as Senior...

September 15, 2014

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--A new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of breast cancer than does conventional IHC-FISH pathology testing.

September 15, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore, the Life Science division of Merck KGaA, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2014.

September 15, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology has released its VIA Spinous Process Fixation System featuring independently compressible superior & inferior plates contoured to maximize the fit between the implant & associated laminae.

September 15, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye.

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kevin Sarney, CPA, has joined Enumeral as VP of Finance and Chief Accounting Officer. Recently transitioning to a public company, Enumeral discovers and develops novel antibody immunotherapies.

September 15, 2014

LONDON--(BUSINESS WIRE)--AHF joins IAPAC, UNAIDS sponsoring London Conference on Antiretrovirals, Sept. 18 & 19--conference to focus on prevention and treatment methods and Treatment as Prevention (TasP)

September 15, 2014

MULHOUSE, France & SAN CARLOS, Calif.--(BUSINESS WIRE)--CellProThera and BioCardia partner in Phase II EXCELLENT Trial studying blood stem cell therapy for acute myocardial infarction delivered via the Helix transendocardial delivery system...

September 15, 2014

LOS ANGELES--(BUSINESS WIRE)--NantBioScience, a NantWorks company focused on the discovery and development of innovative treatments for diseases with high unmet medical need, announced today a research collaboration and an exclusive worldwide...

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the expansion of its management team with the appointments of Karen Anderson as Senior Vice President, Chief...

September 15, 2014

BOSTON--(BUSINESS WIRE)--Zocere will be presenting at the RESI Investor Forum in Boston. The company seeks to raise $1.5 million to advance its neuroprotectant biologic drug for stroke and brain injuries like concussion.

September 15, 2014

BEIJING--(BUSINESS WIRE)--BeiGene (Beijing), Co., Ltd., announced the achievement of a clinical milestone in the company’s collaboration with Merck Serono for BGB-290, an investigational poly polymerase PARP inhibitor.

September 15, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs), today announced top-line...

September 15, 2014

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Commences Trading on the US OTCQX Marketplace

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of...

September 15, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill the...

September 15, 2014

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company initially focused on developing products for oncology, dermatology, ophthalmology and women’s health, today announced that David...

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock announced the appointment of two new members of its Scientific Advisory Board: Barry S. Coller, MD, of The Rockefeller University and Akshay Vaishnaw, MD, PhD, of Alnylam Pharmaceuticals.

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock announced the appointment of Elan Z. Ezickson as Chief Operating Officer and Head of Corporate Development.

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock announced a $20 million Series A financing. Proceeds from the financing will be used to advance proprietary niche modulators from preclinical research toward clinical drug development.

September 15, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced that the U.S. Patent and Trademark Office (USPTO) has issued two new patents related to DX-2930, an investigational fully human monoclonal antibody inhibitor of active...

September 15, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien announced the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascular solutions.

September 15, 2014

NEW DELHI--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has signed non-exclusive licensing agreements with seven India-based generic pharmaceutical manufacturers to expand access to its chronic hepatitis C...

September 15, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck Millipore, the Life Science division of Merck, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2014. The 52nd Annual R&D Awards recognize the...

September 14, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced data from an integrated analysis of survival from two open-label, Phase 2 studies of asfotase alfa in pediatric patients with hypophosphatasia compared with a natural history study.

September 14, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Singapore Institute of Advanced Medicine Holdings (SAM) and ProNova announced today that ProNova has been selected by SAM as its partner to establish the first proton therapy facility in Singapore.

September 13, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical's EnligHTN III study showed safe, rapid and effective treatment with the next-generation EnligHTN™ Renal Denervation System for patients with drug-resistent uncontrolled hypertension

September 13, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--ProNova Solutions & medPhoton will form an exclusive partnership that will merge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market